Skip to content

Inhibitory Learning Based Exposure Response prevention Therapy for Obsessive Compulsive Disorder

Inhibitory Learning-Based Exposure Response Prevention Therapy in Obsessive-Compulsive Disorder: Development and Efficacy trial.

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043229
Enrollment
24
Registered
2022-06-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F40-F48- Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders

Interventions

Intervention1: Inhibitory Learning-based Exposure Response Prevention Therapy for patients with Obsessive-Compulsive Disorder.: 12 - 16 number of sessions with a duration of 1 hour for each session an

Sponsors

Mareena Thampy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Primary diagnosis of OCD as per DMS 5. 2. Patients aged 18 -50 years 3. Y-BOCS score of 16 or greater 4. Education level of minimum class VII. 5. Stabilized on medication for 8 weeks prior to entry into the study. 6. Working knowledge of English or Malayalam language

Exclusion criteria

Exclusion criteria: 1. History suggestive of head injury, neurological/neurosurgical illnesses, 2. A primary diagnosis of, schizophrenia or psychosis, schizoaffective disorder, bipolar disorder with current episode mania/ severe depressive episode, current substance use/substance dependence except for Nicotine Use/Dependence, clinical evidence of intellectual disability. 3. Participants who have undergone more than 6 sessions of structured ERP, CBT, Mindfulness-based CBT, or Metacognitive therapy with ERP in the previous 3 months. 4. People with medical conditions that may be a contraindication for exposure therapy.

Design outcomes

Primary

MeasureTime frame
Symptom severity of OCD as measured by YBOCS symptom severity and Clinical Global Impression Scale (CGI).Timepoint: Baseline 14 weeks (post) 12 weeks after post (1st follow up) 24 weeks after post (2nd Follow up will be attempted)

Secondary

MeasureTime frame
The severity of anxiety (HAM-A)Timepoint: Pre-intervention, post-intervention and follow up;The severity of depression as measured by (HAM-D)Timepoint: Pre-intervention, post-intervention and follow up

Countries

India

Contacts

Public ContactMareena Thampy

National Institute of Mental Health and Neurosciences

paulomi.sudhir@gmail.com08026995184

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026